Advertisements

Contact Jackie Buckle to advertise here:

 

Druglink archive

Nearly 30 years of DrugScope’s magazine, Druglink, dating back to 1986 now available and searchable on the DrugWise website

------------------------

 

Brain Days

 

The brain and addiction - an exciting one day workshop

 

Monday December 4th Leamington Spa

 

An exciting and dynamic, thought provoking one day workshop exploring the wonders of the addictive brain. What works, what doesn’t and why.

 

------------------------

 

ICAAD event
Healing Trauma
In The LGBTQ+ Community

25th November 2017, Royal Garden Hotel, Kensington, London, 9.00am 5.00pm.

 

5 hours CPD available. How to better serve our clients from the LGBTQ+ Community? This one day CPD workshop of presentations and experiential modules threads together important information with takeaway skills as we explore the benefits of being informed, self-aware clinicians in this area. Presented by the USA’s Beck Gee-Cohen, a pioneer in LGBTQ+ addiction/mental health treatment, and one of the UK’s leading psychodrama therapists Adela Campbell. Professional £90 / Student £50 / NHS & Statutory Sector £50. Places limited. Presented by iCAAD Events. Supported by Resort 12

 

-----------------------

 
Comments / sponsorship

If you have any comments about DS Daily or to find out about sponsorship please contact the Editor: Jackie Buckle

 

 

Disclaimer

DS Daily, twitter and Facebook are intended purely as current awareness resources. DS Daily does not endorse nor guarantee the accuracy of the information provided by external sources/links, and accepts no responsibility or liability for any consequences arising from the use of such data. See our editorial policy here

subscribe

 

 

We are pleased to present DS Daily in association with

DDN logo

 

Follow DDN on Facebook


Thank you to our gold sponsors:

 

 

Bristol Drugs Project

 

 

 

Forward Trust logo

 

 
Thank you to our silver sponsors:

 

APCDLOlogo

 

 

Studio House

 

 

Could you sponsor DS Daily? Your logo will appear here with a link to your website. Please Email
Harry Shapiro


Follow DrugScope on Twitter

 

Bookmark and Share

 

...............................


 

 

 

Thank you to our Premium sponsors:

CGL logo

Turning Point

 

Alcohol Research UK

Phoenix Futures logo

 

Addaction

EMCDDA banner

 

Could you sponsor DS Daily? Please Email Harry Shapiro to discuss

Global Drug Survey 2018

Reports November

Follow DrugScope on Twitter

 

Smoking, Drinking and Drug Use Among Young People in England - 2016

This report contains results from an annual survey of secondary school pupils in England in years 7 to 11 (mostly aged 11 to 15). 12,051 pupils in 177 schools completed questionnaires in the autumn term of 2016 | NHS Digital, UK

Drug checking as a harm reduction tool for recreational drug users: opportunities and challenges

A number of European countries have implemented drug checking with the aim of providing targeted preventive messages to recreational drug users | EMCDDA, Portugal

A Public Health Guide to Developing a Community Overdose Response Plan

A new publication by CARBC and Island Health aims to give public-health agencies and community organizations the tools they need to develop a community overdose response plan | CARBC, Canada

Policy and practice briefings: Responding to new psychoactive substances

New psychoactive substances are drugs that are not controlled under the United Nations drug control conventions but which may pose similar threats to health. These drugs include synthetic cannabinoids, opioids, stimulants and hallucinogens. Usually they are marketed as ‘legal’ replacements for the illicit drug market; while some are also used by small groups who wish to explore them for novel experiences and effects | EMCDDA, Portugal

Evidence review summary: drug demand reduction, treatment, and harm reduction

This short report presents a brief overview of recent evidence for the most effective approaches in the fields of drug use prevention, drug use treatment and harm reduction. It discusses the strengths and limitations of the evidence and some challenges for the implementation of the approaches, and it summarises the principles underpinning the successful knowledge transfer that supports the use of evidence in the development and delivery of policy and practice | EMCDDA, Portugal

Opioid Crisis in North America

The opioid-driven public health crisis in North America has reached alarming proportions, contributing in 2016 to an estimated 64,000 deaths from drug overdoses in the US, and some 2,500 in Canada. The members of the Global Commission on Drug Policy, several of whom faced similar crises while occupying the highest levels of government in their own countries, share in this position paper their views and recommendations on how to mitigate this epidemic | GCDP, USA

People who inject drugs: non-fatal overdose monitoring

Report on non-fatal overdose monitoring data collected from the unlinked anonymous monitoring (UAM) survey of HIV, hepatitis B and hepatitis C in people who inject drugs (PWID) | PHE, UK

CLeaR local tobacco control assessment

Guidance for local authorities, public health bodies and the NHS on using ‘deep dive’ self-assessment tools to improve their tobacco control work | PHE, UK

Alcohol-specific deaths in the UK: registered in 2016

Deaths in the UK which are known to be direct consequences of alcohol misuse | ONS, UK

Local Alcohol Profiles for England: November 2017 update

The LAPE interactive tool presents a range of alcohol-related indicators and allows users to view and analyse data in a user-friendly format. The LAPEwebsite also provides links to further supporting and relevant information to aid understanding of alcohol-related harm in a local population | PHE, UK

Local Alcohol Profiles for England: November 2017 (PDF)

This latest update to the Local Alcohol Profiles for England (LAPE) includes the addition of 2016 deaths | PHE, UK

Vaping solutions: an easy Brexit win (PDF)

IEA releases report on why we need to allow the e-cigarette market to grow | IEA, UK

Drug-related infectious diseases in Europe: update from the EMCDDA expert network

This report provides an update on infectious diseases related to injecting drug use in Europe. It covers both the EMCDDA Drug-related infectious diseases indicator, which collects data on the situation, and the responses in the area. The report is based on the indicator’s annual expert meeting, held in Lisbon in June 2017, which brought together national experts from the 28 EU Member States, Norway, Turkey, European neighbourhood countries and partner organisations | EMCDDA, Portugal

Alcohol licensing: a guide for public health teams

Public health teams make sure that licensing policy and applications consider the health and wellbeing of local communities | PHE, UK

EMCDDA–Europol Joint Report on a new psychoactive substance: methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate (carfentanil)

In May 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate (carfentanil), through a joint assessment. The two organisations launched a data collection on this substance for the preparation of a Joint Report as stipulated by Article 5.1 of the Council Decision. The Joint Report was submitted to the Council, the Commission and the European Medicines Agency on 27 July 2017 | EMCDDA, Portugal

Afghan opium production jumps to record level, up 87 per cent: Survey

Opium production in Afghanistan increased by 87 per cent to a record level of 9,000 metric tons in 2017 compared with 2016 levels, according to the latest Afghanistan Opium Survey figures released today by the Afghan Ministry of Counter Narcotics and UNODC. The area under opium poppy cultivation also increased to a record 328,000 hectares (ha) in 2017, up 63 per cent compared with 201,000 hectares in 2016 | UNODC, Switzerland

EMCDDA–Europol Joint Report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-furan-2-carboxamide (furanylfentanyl)

In November 2016, the EMCDDA and Europol examined the available information on a new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-furan-2-carboxamide, commonly known as furanylfentanyl, through a joint assessment | EMCDDA, Portugal

HIV testing in England

This report provides a single resource for national monitoring data for HIVtesting activity in England and reviews the implementation of national and European HIV testing guidelines | PHE, UK

Commission lays out roadmap for fairer and safer gambling

The Gambling Commission has today unveiled a new strategy which will help shape a well-regulated gambling market that works for consumers | Gambling Commission, UK

Public Health England - Evaluation and recommendations (PDF)

Public Health England (PHE) is an executive agency of the Department of Health (DH). PHE is the expert national public health agency, which fulfills the Secretary of State for Health’s statutory duties to protect health and address health inequalities, and executes the Secretary of State’s power to promote the health and wellbeing of the nation | IANPHI, UK

Alcohol Related Hospital Statistics

This publication from the Information Services Division provides an annual update to figures on alcohol-related inpatient and day case activity within general acute hospitals and psychiatric hospitals in Scotland. This release covers general acute hospital activity for the financial years 1981/82 to 2016/17 and psychiatric hospital admissions from 1997/98 to 2015/16 | ISD, UK

PHE announces areas for IPS alcohol and drug dependency trial

Seven areas to take part in individual placement and support (IPS) trial for drugs or alcohol dependency in community treatment services | PHE, UK

Tobacco products and e-cigarette cross-border sales registration

How businesses that supply tobacco products and e-cigarettes via cross-border distance sales can register with the UK government | PHE, UK

Public Health England - Evaluation and recommendations (PDF)

Public Health England (PHE) is an executive agency of the Department of Health (DH). PHE is the expert national public health agency, which fulfills the Secretary of State for Health’s statutory duties to protect health and address health inequalities, and executes the Secretary of State’s power to promote the health and wellbeing of the nation | IANPHI, UK